Natera Oncology’s Post

💗Pink is the color of Breast Cancer Awareness Month💗 Throughout October, our Brainlab Tower in Munich will be lit pink as a symbol for our support for Breast Cancer Awareness Month. At Brainlab, we are working on products every single day to have better chances in the fight against cancer. Breast cancer is still one of the most common cancers affecting women around the globe. Early detection and innovative treatments are key to improving patients outcome. If you want to learn more about how we're innovating in breast cancer treatment, click here: https://lnkd.in/ezYAHu7r #radiotherapy #radiosurgery #TogetherWeFightCancer #WeAreBrainab #Oncology #BreastCancer #pinkoctober

🌟 We’re thrilled to introduce Dr. Piotr J. Wysocki (Poland) as a speaker at the Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer Conference, taking place online from December 6-8, 2024! Dr. Wysocki will address a crucial question for colorectal cancer care: “Colorectal Cancer with Liver Metastasis — How Can We Increase the Chances of Cure?” 📅 Save the date and join us for three days of transformative discussions and insights with global experts, patients, and advocates in the field of colorectal cancer. 👉 To learn more or register, follow the link below: https://lnkd.in/dNgP7N6U #GlobalCancerMovement #ColorectalCancer #CancerInnovation #OncoDaily #Cancer #Oncology

🌸 Today is #InternationalDayAgainstBreastCancer 🎗 On October 19th, we stand together in the fight against breast cancer. At RadioVal, we're proud to be part of this effort through our pioneering research 🤲 🌍 RadioVal is the first multi-centre, multi-continental clinical validation study using radiomics to predict responses to neoadjuvant chemotherapy (NAC) in breast cancer. By analysing breast MRI scans, we aim to personalise treatment plans and improve patient outcomes globally 💓 Join us in supporting the future of breast cancer treatment 🙏 #HorizonEU #EUFunded #BreastCancer

The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer - Dana-Farber Cancer Institute American Society of Clinical Oncology (ASCO) Angela DeMichele MD, MSCE, FASCO Harold Burstein #ASCO #BreastCancer #Cancer #DanaFarberBreastOncologyCenter #OncoDaily #Oncology

The San Antonio Breast Cancer Symposium (SABCS) 2024 abstracts (including late-breaking!) are live! Get ready to explore the latest in breast cancer research at SABCS 2024 in San Antonio, Texas, December 10-13. LARVOL will be at the conference, showcasing the key oncology data solutions designed to transform research and patient care. Let's connect to uncover insights, spark innovation, and drive impactful collaborations in the fight against cancer. Mark your calendar and meet us there! #LARVOL #SABCS24 #CancerResearch #Oncology #OncologyUpdates #BreastCancer #CancerData #CancerCare

🎗 Breast Cancer Awareness Month Special: Join Our Free Webinar! 🎗 🗓 Date: Thursday, 24 October 2024 🕛 Time: 12:00 PM - 1:00 PM (UAE) 👩⚕ Guest Speaker: Dr. Charu Garg, Senior Director in Radiation Oncology at Max Super Specialty Hospital, Saket. Join us as Dr. Garg shares her expertise on breast and gynecological cancers during this special Breast Cancer Awareness Month session. 🌸 Key Takeaways: - Understanding cancer risk factors - Preventative strategies - Insights on breast cancer awareness and treatment options 👉 Register now by sending us a message. #BreastCancerAwarenessMonth #Webinar #HealthEducation #DrCharuGarg #Oncology #LinkedInLearning

Latest breast cancer insights from ESMO - European Society for Medical Oncology Congress by SPCC (Sharing Progress in Cancer Care) SPCC (Sharing Progress in Cancer Care) is hosting a live session to share key updates on breast cancer for those who missed the ESMO Congress. The session will cover topics on Early Breast Cancer (EBC) and Advanced Breast Cancer (ABC), providing valuable insights for participants. Fatima Cardoso Shani Paluch-Shimon https://lnkd.in/evSrh554 #BreastCancer #ESMO2024 #ESMOCongress2024 #OncoDaily #Oncology #Cancer #Health #Medicine

ALCMI's research is driving forward our understanding of lung cancer, specifically how it impacts young people, familial risk factors, and resistance mechanisms. We're proud to have published studies in the International Association for the Study of Lung Cancer's JTO Clinical and Research Reports and in the American Society of Clinical Oncology (ASCO)'s Journal of Clinical Oncology. Join us! Let's work together to advance our understanding of this disease. #lungcancer #cancer #oncology

Read our new interview with Dr. Cristian Scatena: Predicting response to neoadjuvant chemotherapy in HER2-positive breast cancers using MammaTyper®. Dr. Cristian Scatena, a pathologist specializing in breast cancer, presented research at European Breast Cancer Conference in Milan on predicting neoadjuvant chemotherapy response in HER2-positive breast cancers using MammaTyper® The study showed promising results in predicting response using MammaTyper®, with factors like Ki67 and progesterone receptor proving important beyond HER2 mRNA expression. If successful, this approach could guide personalized treatment decisions, potentially reducing unnecessary chemotherapy. Read our full article via the link: #BreastCancer #Pathology #ArtificialIntelligence